tjh-v38i2
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Kaya Z. et al: ALPS in Chronic Immune Cytopenia and Lymphoma
Turk J Hematol 2021;38:145-150
22. George LA, Teachey DT. Optimal management of autoimmune
lymphoproliferative syndrome in children. Paediatr Drugs 2016;18:261-272.
23. Rao VK, Dugan F, Dale JK, Davis J, Tretler J, Hurley JK, Fleisher T, Puck J,
Straus SE. Use of mycophenolate mofetil for chronic, refractory immune
cytopenias in children with autoimmune lymphoproliferative syndrome. Br
J Haematol 2005;129:534-538.
24. Teachey DT, Greiner R, Seif A, Attiyeh E, Bleesing J, Choi J, Manno C,
Rappaport E, Schwabe D, Sheen C, Sullivan KE, Zhuang H, Wechsler DS,
Grupp SA. Treatment with sirolimus results in complete responses in
patients with autoimmune lymphoproliferative syndrome. Br J Haematol
2009;145:101-106.
25. Koçak U, Aral YZ, Kaya Z, Öztürk G, Gürsel T. Evaluation of clinical
characteristics, diagnosis and management in childhood immune
thrombocytopenic purpura: a single center’s experience. Turk J Pediatr
2007;49:250-255.
26. Sarper N, Kılıç SÇ, Zengin E, Gelen SA. Management of autoimmune
hemolytic anemia in children and adolescents: a single center. Turk J
Haematol 2011;28:198-205.
27. Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, Perkins K, Hornung RL,
Folio L, Rosenberg PS, Puck JM, Hsu AP, Lo B, Pittaluga S, Jaffe ES, Fleisher
TA, Rao VK, Lenardo MJ. Natural history of autoimmune lymphoproliferative
syndrome associated with FAS gene mutations. Blood 2014;123:1989-1999.
28. Roberts CA, Ayers L, Bateman EA, Sadler R, Magerus-Chatinet A, Rieux-
Laucat F, Misbah SA, Ferry BL. Investigation of common variable
immunodeficiency patients and healthy individuals using autoimmune
lymphoproliferative syndrome biomarkers. Hum Immunol 2013;74:1531-
1535.
29. Del-Rey M, Ruiz-Contreras J, Bosque A, Calleja S, Gomez-Rial J, Roldan
E, Morales P, Serrano A, Anel A, Paz-Artal E, Allende LM. A homozygous
Fas ligand gene mutation in a patient causes a new type of autoimmune
lymphoproliferative syndrome. Blood 2006;108:1306-1312.
30. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni
A, Franco JL, Holland SM, Klein C, Morio T, Ochs HD, Oksenhendler E, Picard
C, Puck J, Torgerson TR, Casanova JL, Sullivan KE. Human inborn errors of
immunity: 2019 update on the classification from the International Union
of Immunological Societies Expert Committee. J Clin Immunol 2020;40:24-
64.
150